U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07410403) titled 'AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities' on June 16, 2025.
Brief Summary: This study developed an artificial intelligence (AI)-based methodology for the quantitative analysis of single-cell morphological data in multiple myeloma (MM). The approach achieves high-precision AI-driven identification and segmentation of myeloma cells, nuclei, cytoplasm, and nucleoli, overcoming the inherent limitations of subjective traditional morphological analysis.
Furthermore, integrating this morphological quantification with cytogenetic abnormality analysis of myeloma cells provides an effici...